Abbott and Omada Health Partner to Help People With Type 2 Diabetes

On October 14, 2019, Abbott and Omada Health announced a partnership to integrate Abbott's FreeStyle Libre continuous glucose monitoring system (CGM) with Omada Health's digital program for people with Type 2 diabetes.

Abbott’s FreeStyle Libre Receives Reimbursement in Ontario and Quebec

Abbott FreeStyle Libre announced on Friday, September 13, 2019, it received public reimbursement in Canada's two largest provinces, Ontario and Quebec, for it's FreeStyle Libre System. The news makes FreeStyle Libre the first sensor-based glucose monitoring system to be listed by any provincial health plan in Canada.

CGM: Continuous Glucose Monitor

Continuous glucose monitors (CGMs) are tools used to measure glucose levels on a continuous basis. For people with Type 2 diabetes, CGMs can be a major step to consistent glucose monitoring, understanding their glucose trends, and keeping their levels in a safe and healthy range.